Literature DB >> 11377641

Place of bupropion in smoking-cessation therapy.

C Silagy1, N Formica.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11377641     DOI： 10.1016/S0140-6736(00)04781-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Current approaches to the management of smoking cessation.

Authors:  Gay Sutherland
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  [More drugs to cure disorders in human relations? The case of addiction to tobacco].

Authors:  J L Turabián-Fernández; B Pérez-Franco
Journal:  Aten Primaria       Date:  2006-01       Impact factor: 1.137

Review 3.  Benefits and risks of pharmacological smoking cessation therapies in chronic obstructive pulmonary disease.

Authors:  Edwin J Wagena; Maurice P A Zeegers; Constant P van Schayck; Emiel F M Wouters
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 4.  Nicotine addiction through a neurogenomic prism: ethics, public health, and smoking.

Authors:  Lorraine Caron; Katrina Karkazis; Thomas A Raffin; Gary Swan; Barbara A Koenig
Journal:  Nicotine Tob Res       Date:  2005-04       Impact factor: 4.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.